ASSESSMENT OF LIVER FIBROSIS IN INDIVIDUALS WITH METABOLIC SYNDROME OR TYPE 2 DIABETES MELLITUS USING NON-INVASIVE TESTS

被引：0
|
作者：
Nastasa, Robert [1 ]
Stanciu, Carol [1 ]
Stratina, Ermina [1 ]
Zenovia, Sebastian [1 ]
Muzica, Cristina [1 ]
Stafie, Remus [1 ]
Adrian, Rotaru [1 ]
Minea, Horia [1 ]
Huiban, Laura [1 ]
Chiriac, Stefan [1 ]
Sfarti, Catalin [1 ]
Cojocariu, Camelia [1 ]
Cuciureanu, Tudor [1 ]
Singeap, Ana-Maria [1 ]
Girleanu, Irina [1 ]
Trifan, Anca [1 ]
机构：
[1] Univ Med & Pharm Grigore T Popa, Iasi, Romania
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2402-C
引用
收藏
页码：S1154 / S1154
页数：1
相关论文
共 50 条
  • [41] HOW EFFECTIVE IS A 'CLINICAL FIBROSIS ASSESSMENT' USING NON-INVASIVE FIBROSIS TESTS IN PATIENTS WITH NAFLD?
    McPherson, Stuart
    Dyson, Jessica
    Jopson, Laura
    Masson, Steven
    Patel, Preya
    Anstee, Quentin
    GUT, 2023, 72 : A24 - A25
  • [42] HOW EFFECTIVE IS A 'CLINICAL FIBROSIS ASSESSMENT' USING NON-INVASIVE FIBROSIS TESTS IN PATIENTS WITH NAFLD?
    McPherson, Stuart
    Dyson, Jessica
    Jopson, Laura
    Masson, Steven
    Patel, Preya
    Anstee, Quentin
    GUT, 2023, 72 (SUPPL_3) : A24 - A25
  • [43] Using non-invasive assessment methods to predict the risk of metabolic syndrome
    Hsiung, Der-Yun
    Liu, Chia-Wei
    Cheng, Pi-Chen
    Ma, Wei-Fen
    APPLIED NURSING RESEARCH, 2015, 28 (02) : 72 - 77
  • [44] Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
    Grobbee, Esmee J.
    de Jong, Vivian D.
    Schrieks, Ilse C.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    Tardif, Jean-Claude
    Lincoff, A. Michael
    Schwartz, Gregory G.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    PLOS ONE, 2022, 17 (11):
  • [45] Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus
    Meritsi, Angeliki
    Latsou, Dimitra
    Tsorlalis, Ioannis
    Noutsou, Marina
    Manesis, Emanuel
    Gatos, Ilias
    Theotokas, Ioannis
    Zoumpoulis, Pavlos
    Rapti, Stamatia
    Tsitsopoulos, Eustathios
    Moshoyianni, Hariklia
    Manolakopoulos, Spilios
    Pektasides, Dimitrios
    Thanopoulou, Anastasia
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S3 - S3
  • [46] Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease
    Liguori, Antonio
    Zoncape, Mirko
    Tsochatzis, Emmanuel A.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (04) : 191 - 194
  • [47] Assessment of left ventricular function in patients with type 2 diabetes mellitus by non-invasive myocardial work
    Cao, Wenjia
    Deng, Yan
    Lv, Linyi
    Liu, Xuebing
    Luo, Anguo
    Yin, Lixue
    Li, Zhaohuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [48] Are non-invasive tests of fibrosis effective in patients with metabolic associated fatty liver disease? Comparative study between liver biopsy and non-invasive scores or fibroscan
    Cespiati, Annalisa
    Lombardi, Rosa
    Carvalhana, Sofia
    Smith, Daniel
    Bertelli, Cristina
    Pisano, Giuseppina
    Cortez-Pinto, Helena
    Fracanzani, Anna Ludovica
    JOURNAL OF HEPATOLOGY, 2023, 78 : S722 - S723
  • [49] Non-invasive detection of liver fibrosis in patients hospitalized with diabetes
    Gonzalez, C.
    Rigalleau, V.
    Maury, E.
    Gin, H.
    Beauvieux, M. -C.
    Vergniol, J.
    Foucher, J.
    Villars, S.
    De Ledinghen, V.
    DIABETES & METABOLISM, 2011, 37 : A77 - A77
  • [50] Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan®
    Marcellin, P
    De Ledinghen, V
    Dhumeaux, D
    Poupon, R
    Ziol, M
    Bedossa, P
    Beaugrand, M
    HEPATOLOGY, 2005, 42 (04) : 715A - 716A
12345